Ovarian Cancer (BRCA Mutation): Molecular Oncology Tumor Boards

This free case-based activity includes a crowd-sourced discussion of a 62-year-old woman with frequent abdominal bloating and urination for 3 months, now with pelvic pain is referred by a gynecologist for evaluation.  Ultrasound shows an 8.5cm complex right ovarian mass with a moderate amount of free fluid in the pelvis. There is no abnormal vaginal bleeding.  Baseline labs are significant for thrombocytosis with platelets of 650 K/uL, CA125 of 394 U/mL, and CEA of 1.6 ng/mL.  Family history is unremarkable. Abdominal exam is normal, pelvic exam demonstrates a mobile right adnexal mass.

Originally posted on a forum in the ASCO Connection, users now have the opportunity to claim CME, completion, or participation certificates for completing this activity.

Learning Objectives
1.    Describe when ovarian cancers need to be sent for genetic testing and how results influence therapy
2.    Identify role of targeted therapy in high grade serous ovarian carcinoma
3.    Analyze the molecular method and role of next generation sequencing in recurrent ovarian high grade serous carcinomas

Continuing Education Credit

1 Credit/Point is available for participation in this course. Certificate and credit types available include:

  • AMA PRA Category 1 Credits
  • ABIM MOC Points
  • CNE Contact Hours
  • CPE Credits
  • Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
  • Certificate of Completion may be used to document participation, but no credit will be conferred.

Important Note: This course expires on July 26, 2020. Participants must complete all necessary course components by this date to receive credit.